World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
61
Citations
18182
World Ranking
1884
National Ranking
939

Scott C. Kogan publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Scott C. Kogan sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 193 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Scott C. Kogan D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Scott C. Kogan sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 61 D-Index — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Scott C. Kogan is affiliated with the University of California, San Francisco in the United States. Their research spans primarily across the fields of Medicine and Biochemistry, Genetics, and Molecular Biology, with significant work in molecular biology, public health, pediatrics, oncology, and hematology.

The scientist has contributed extensively to several main research topics, including:

  • Acute Lymphoblastic Leukemia research
  • Childhood Cancer Survivors' Quality of Life
  • Acute Myeloid Leukemia Research
  • Cytokine Signaling Pathways and Interactions
  • PI3K/AKT/mTOR signaling in cancer
  • Immune Cell Function and Interaction
  • Chronic Lymphocytic Leukemia Research

Frequent publication venues for their work include:

  • Blood
  • Cancer Epidemiology Biomarkers & Prevention
  • Haematologica
  • American Journal of Epidemiology
  • Leukemia

They have collaborated often with several researchers, among the most frequent co-authors are:

  • Joseph L. Wiemels
  • Catherine Metayer
  • Adam J. de Smith
  • Kevin Shannon
  • Mi Zhou

Some of their recent papers are:

  • RASA2 ablation in T cells boosts antigen sensitivity and long-term function, 2022, Nature
  • Trends in Acute Lymphoblastic Leukemia Incidence in the United States by Race/Ethnicity From 2000 to 2016, 2020, American Journal of Epidemiology
  • Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia, 2020, Leukemia
  • Genetic disruption of N-RasG12D palmitoylation perturbs hematopoiesis and prevents myeloid transformation in mice, 2020, Blood
  • KrasP34R and KrasT58I mutations induce distinct RASopathy phenotypes in mice, 2020, JCI Insight

Best Publications

  • RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

    Johannes Zuber;Junwei Shi;Junwei Shi;Eric Wang;Amy R. Rappaport;Amy R. Rappaport

  • Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy.

    Hans-Guido Wendel;Elisa de Stanchina;Jordan S. Fridman;Jordan S. Fridman;Abba Malina

  • An Improved Method for Prenatal Diagnosis of Genetic Diseases by Analysis of Amplified DNA Sequences: Application to Hemophilia A

    Scott C. Kogan;Marie Doherty;Jane Gitschier

  • Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity

    Yuchen Chien;Claudio Scuoppo;Xiaowo Wang;Xueping Fang

  • A PMLRARα transgene initiates murine acute promyelocytic leukemia

    Diane Brown;Scott Kogan;Eric Lagasse;Irving Weissman

  • Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice.

    Scott C. Kogan;Jerrold M. Ward;Miriam R. Anver;Jules J. Berman

  • Retinoic Acid and Arsenic Synergize to Eradicate Leukemic Cells in a Mouse Model of Acute Promyelocytic Leukemia

    Valérie Lallemand-Breitenbach;Marie-Claude Guillemin;Anne Janin;Marie-Thérèse Daniel

  • Inhibition of apoptosis by the retinoblastoma gene product.

    Unknown

  • Bethesda proposals for classification of lymphoid neoplasms in mice

    Herbert C. Morse;Miriam R. Anver;Torgny N. Fredrickson;Diana C. Haines

  • Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder.

    Benjamin S. Braun;David A. Tuveson;Namie Kong;Doan T. Le

  • A rapid and scalable system for studying gene function in mice using conditional RNA interference.

    Prem K Premsrirut;Prem K Premsrirut;Lukas E Dow;Sang Yong Kim;Matthew Camiolo;Matthew Camiolo

  • mTORC1 promotes survival through translational control of Mcl-1

    John R. Mills;Yoshitaka Hippo;Francis Robert;Samuel M. H. Chen

  • MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia.

    Chong Chen;Yu KiKi Liu;Amy R Rappaport;Thomas Kitzing

  • Mouse models of human AML accurately predict chemotherapy response

    Johannes Zuber;Ina Radtke;Timothy S. Pardee;Zhen Zhao

  • An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance

    Johannes Zuber;Amy R. Rappaport;Weijun Luo;Eric Wang

  • Functional dissection and sequence of yeast HAP1 activator

    Karl Pfeifer;Kwang-Soo Kim;Scott Kogan;Leonard Guarente

  • New evidence supporting megakaryocyte-erythrocyte potential of flk2/flt3+ multipotent hematopoietic progenitors.

    E. Camilla Forsberg;Thomas Serwold;Scott Kogan;Irving L. Weissman

  • Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders

    John M. Joslin;Anthony A. Fernald;Thelma R. Tennant;Elizabeth M. Davis

  • Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder.

    Doan T. Le;Namie Kong;Yuan Zhu;Jennifer O. Lauchle

  • Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family.

    Patrick Viatour;Tim C. Somervaille;Shivkumar Venkatasubrahmanyam;Scott Kogan

Frequent Co-Authors

Kevin Shannon
Kevin Shannon University of California, San Francisco
Scott W. Lowe
Scott W. Lowe Memorial Sloan Kettering Cancer Center
Michelle M. Le Beau
Michelle M. Le Beau University of Chicago
Johannes Zuber
Johannes Zuber Research Institute of Molecular Pathology
Irving L. Weissman
Irving L. Weissman Stanford University
Joseph L. Wiemels
Joseph L. Wiemels University of Southern California
Christine Chomienne
Christine Chomienne Université Paris Cité
Jane Gitschier
Jane Gitschier University of California, San Francisco
Anne Janin
Anne Janin Université Paris Cité
David A. Largaespada
David A. Largaespada University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology often raises questions about flexible career options and pathways. Many related fields now offer convenient online degree programs, making it easier to balance study, work, and other commitments.

If you’re interested in science communication or information management, consider the cost of mlis degree us—a pathway into libraries, research institutions, and information science. For those fascinated by healthcare and communication, speech-language pathology is another in-demand field. Accredited programs are essential; check out asha approved slp programs for online options that meet national standards.

Individuals with a background in molecular or biological sciences can transition into clinical speech-language roles through slp bridge programs, which are designed specifically for non-SLP majors. Additionally, if you’re considering a shift to nursing, accelerated bsn programs for non nurses enable a rapid transition into nursing careers—even without prior nursing experience.

Each of these online pathways offers flexibility, affordability, and diverse career prospects, making them excellent alternatives or complements to molecular biology training.

Best Scientists Citing Scott C. Kogan

Trending Scientists

Recently Published Articles